Lung cancer study seeks metabolic clues to boost immunotherapy
NCT ID NCT07637474
First seen Jun 09, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This study looks at how the body's metabolism influences whether immunotherapy works in people with non-small cell lung cancer (NSCLC). Researchers will collect and analyze tissue samples from 150 patients to find patterns linked to treatment response or resistance. The goal is to discover new biomarkers and pathways that could lead to better combination therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS National Cancer institute
RECRUITINGRome, Rome, 00144, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.